CD109 and squamous cell carcinoma: It has been implicated in breast cancer [23] (where RNAi knockdown of CD109 suppressed malignant growth and CD109 shed from the cell surface has a pro-growth function), squamous cell carcinoma of the oral cavity [21] and is upregulated in various tumour cell lines including GBM cell lines [22].